Tham khảo Canrenone

  1. ↑ Jürg Müller (6 tháng 12 năm 2012). Regulation of Aldosterone Biosynthesis: Physiological and Clinical Aspects. Springer Science & Business Media. tr. 164–. ISBN 978-3-642-83120-1.
  2. ↑ Gardiner P, Schrode K, Quinlan D, Martin BK, Boreham DR, Rogers MS, Stubbs K, Smith M, Karim A (1989). “Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites”. J Clin Pharmacol. 29 (4): 342–7. doi:10.1002/j.1552-4604.1989.tb03339.x. PMID 2723123.
  3. ↑ Losert, W; Casals-Stenzel, J; Buse, M (1985). “Progestogens with antimineralocorticoid activity”. Arzneimittelforschung. 35 (2): 459–71. PMID 4039568.
  4. ↑ Fernandez, MD; Carter, GD; Palmer, TN (1983). “The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol”. Br J Clin Pharmacol. 15 (1): 95–101. doi:10.1111/j.1365-2125.1983.tb01470.x. PMC 1427833. PMID 6849751.
  5. 1 2 3 J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 210–. ISBN 978-1-4757-2085-3.
  6. 1 2 Hill, R.A.; Makin, H.L.J.; Kirk, D.N.; Murphy, G.M. (23 tháng 5 năm 1991). Dictionary of Steroids. CRC Press. tr. 656–. ISBN 978-0-412-27060-4.
  7. ↑ Romanelli, RG; Gentilini, P (tháng 5 năm 2004). “Cross reactivity due to positive canrenone interference”. Gut. 53 (5): 772–3. PMC 1774040. PMID 15082604.
  8. 1 2 3 Index Nominum 2000: International Drug Directory. Taylor & Francis. tháng 1 năm 2000. tr. 167–. ISBN 978-3-88763-075-1.
  9. 1 2 Clark, Michelle A.; Harvey, Richard A.; Finkel, Richard; Rey, Jose A.; Whalen, Karen (15 tháng 12 năm 2011). Pharmacology. Lippincott Williams & Wilkins. tr. 286–. ISBN 978-1-4511-1314-3.
  10. ↑ Sobbrio, GA; Granata, A; Panacea, A; Trimarchi, F (1989). “Effectiveness of short term canrenone treatment in idiopathic hirsutism”. Minerva Endocrinol. 14 (2): 105–8. PMID 2761494.
  11. ↑ Coelingh Benni, H.J.T.; Vemer, H.M. (15 tháng 12 năm 1990). Chronic Hyperandrogenic Anovulation. CRC Press. tr. 152–. ISBN 978-1-85070-322-8.
  12. ↑ Seldin, Donald W.; Giebisch, Gerhard H. (23 tháng 9 năm 1997). Diuretic Agents: Clinical Physiology and Pharmacology. Academic Press. tr. 630–. ISBN 978-0-08-053046-8.
  13. ↑ Colby, HD (1981). “Chemical suppression of steroidogenesis”. Environ. Health Perspect. 38: 119–27. doi:10.1289/ehp.8138119. PMC 1568425. PMID 6786868.
  14. ↑ Pere Ginés; Vicente Arroyo; Juan Rodés; Robert W. Schrier (15 tháng 4 năm 2008). Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. John Wiley & Sons. tr. 229. ISBN 978-1-4051-4370-7.
  15. ↑ Maron BA, Leopold JA (2008). “Mineralocorticoid receptor antagonists and endothelial function”. Curr Opin Investig Drugs. 9 (9): 963–9. PMC 2967484. PMID 18729003.
  16. ↑ International Agency for Research on Cancer; World Health Organization (2001). Some Thyrotropic Agents. World Health Organization. tr. 325–. ISBN 978-92-832-1279-9.
  17. ↑ Agusti G, Bourgeois S, Cartiser N, Fessi H, Le Borgne M, Lomberget T (2013). “A safe and practical method for the preparation of 7α-thioether and thioester derivatives of spironolactone”. Steroids. 78 (1): 102–7. doi:10.1016/j.steroids.2012.09.005. PMID 23063964.
  18. 1 2 William Andrew Publishing (22 tháng 10 năm 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. tr. 804–. ISBN 978-0-8155-1856-3.
  19. ↑ https://www.drugs.com/international/canrenone.html
  20. ↑ https://www.drugs.com/international/potassium-canrenoate.html

Liên quan